Merit Medical stock maintains Buy rating on preliminary results

2 days ago · On Tuesday, Needham reaffirmed its positive stance on shares of Merit Medical Systems , Inc. (NASDAQ:MMSI), a $5.57 billion medical device company, with a Buy rating …

$5.57
OFF

Merit Medical Stock Maintains Buy Rating On Preliminary Results

2 weeks from now

2 days ago · On Tuesday, Needham reaffirmed its positive stance on shares of Merit Medical Systems , Inc. (NASDAQ:MMSI), a $5.57 billion medical device company, with a Buy rating …

investing.com

$92.00
OFF

Merit Medical Systems (NASDAQ:MMSI) Earns "Buy" Rating

2 weeks from now

2 days ago · Finally, Bank of America lifted their price target on shares of Merit Medical Systems from $92.00 to $103.00 and gave the stock a "neutral" rating in a research note on Monday, …

marketbeat.com

$5.57
OFF

Merit Medical Stock Maintains Buy Rating On Preliminary Results

2 weeks from now

2 days ago · On Tuesday, Needham reaffirmed its positive stance on shares of Merit Medical Systems , Inc. (NASDAQ: MMSI), a $5.57 billion medical device company, with a Buy rating …

investing.com

40%
OFF

Merit Medical Systems: Solid Execution, Stretched Valuations

2 weeks from now

Jan 8, 2025 · Merit Medical Systems' stock is up 40% from last spring's lows, driven by strong Q3 results and positive analyst sentiment. ... Needham and Raymond James have reissued Buy …

seekingalpha.com

$88.00
OFF

Merit Medical Systems Earns ‘Buy’ Rating On ... - Markets Insider

2 weeks from now

Feb 29, 2024 · Analyst Michael Matson of Needham reiterated a Buy rating on Merit Medical Systems (MMSI – Research Report), with a price target of $88.00...

businessinsider.com

$105.00
OFF

Needham Maintains Buy Rating On Merit Medical Stock After …

2 weeks from now

Sep 16, 2024 · Needham has maintained a Buy rating on Merit Medical Systems , Inc. (NASDAQ: NASDAQ: MMSI) with a price target of $105.00.The endorsement follows the presentation of …

investing.com

$105.00
OFF

Merit Medical Stock Retains Outperform Rating As Margin …

2 weeks from now

Dec 31, 2024 · On Tuesday, Raymond (NS:RYMD) James increased its price target for Merit Medical Systems , Inc. (NASDAQ:MMSI) shares from $105.00 to $110.00, while maintaining …

investing.com

$100.56
OFF

9 Analysts Assess Merit Medical Systems: What You Need To Know

2 weeks from now

Aug 28, 2024 · Analysts have set 12-month price targets for Merit Medical Systems, revealing an average target of $100.56, a high estimate of $125.00, and a low estimate of $92.00.

nasdaq.com

$105.00
OFF

Where Merit Medical Systems Stands With Analysts - Nasdaq

2 weeks from now

Oct 18, 2024 · 11 analysts have expressed a variety of opinions on Merit Medical ... Maintains: Buy: $105.00: $105.00: Jason Bednar: ... and engage with insiders to generate quarterly …

nasdaq.com

9%
OFF

Merit Medical Stock Gains Following Solid Preliminary Q4 Revenues

2 weeks from now

1 day ago · Merit Medical Systems, Inc. MMSI announced preliminary revenues for 2024 on Monday. Following the robust preliminary results, the company’s shares gained nearly 3.9% till …

nasdaq.com

FAQs about Merit Medical stock maintains Buy rating on preliminary results Coupon?

Is Merit Medical Systems (MMS) a great stock to buy?

According to analysts, Merit Medical Systems (MMS) is a buy stock. The company has a consensus rating of Buy and an average rating score of 2.83, based on 5 buy ratings, 1 hold rating, and no sell ratings. The consensus price target is $76.33, indicating a forecasted upside of 10.7% from its current price of $68.95. ...

Should you buy Merit Medical Systems (MMSI)?

A PEG ratio of 1.5 to 2 seems much more reasonable, especially with no dividend payout. Merit Medical Systems also carries a slug of debt as well. Therefore, an investor could more reasonably buy MMSI in the $55 to $73 a share range if the stock pulls back to those levels. ...

Does Merit Medical Systems pay a dividend?

The equity does not pay a dividend. As you can see above, that is in the upper end of the company's historical price to sales range. Merit Medical Systems looks like it will average around 11% annual earnings growth FY2023 through FY2025. This means the stock trades with a PEG ratio of just north of 2.6 PEG ratio. ...

Why did Michael Matson buy Merit Medical Systems?

Michael Matson has given his Buy rating due to a combination of factors including Merit Medical Systems’ strong performance in the fourth quarter of 2023, as evidenced by their solid free cash flow. The company reported an increase in their organic revenue growth, which escalated from 7.1% in the third quarter to 8.3% in the fourth quarter. ...

Why did Michael Petusky buy Merit Medical Systems?

Michael Petusky has given his Buy rating due to a combination of factors including Merit Medical Systems’ strong financial performance and strategic developments. The company reported third-quarter revenue slightly above expectations, with significant growth in its endoscopy segment, largely driven by recent mergers and acquisitions. ...